A basic review on systemic treatment options in WHO grade II-III gliomas.
Cancer Treat Rev. 2021 Jan;92:102124. doi: 10.1016/j.ctrv.2020.102124. Epub 2020 Nov 13.
Cancer Treat Rev. 2021.
PMID: 33227622
Free article.
Review.
WHO grade II-III gliomas are rare primary brain tumors occurring at a median age of about 35-55 years. Median survival is longer in WHO grade II-III glioma compared with WHO grade IV glioblastoma as survival times of up to 10 years and longer can be observed. ...The …
WHO grade II-III gliomas are rare primary brain tumors occurring at a median age of about 35-55 years. Median survival is longer in WHO grad …